Nifty
Sensex
:
:
11932.60
39719.03
88.50 (0.75%)
284.31 (0.72%)

Pharmaceuticals & Drugs

Rating :
57/99

BSE: 524348 | NSE: AARTIDRUGS

570.00
4.00 (0.71%)
27-May-2019 | 2:19PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  566.10
  •  575.00
  •  566.10
  •  566.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6524
  •  37.19
  •  707.00
  •  475.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,324.96
  • 14.76
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,866.94
  • 0.18%
  • 2.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.26%
  • 0.00%
  • 29.29%
  • FII
  • DII
  • Others
  • 0.01%
  • 4.06%
  • 4.38%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.53
  • 3.25
  • 2.95

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.75
  • 4.29
  • 2.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.29
  • 3.84
  • 6.20

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.96
  • 17.67
  • 16.90

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.90
  • 3.92
  • 3.13

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.14
  • 11.00
  • 9.59

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
459.14
330.69
38.84%
380.11
335.41
13.33%
347.41
319.27
8.81%
374.29
277.20
35.03%
Expenses
403.23
274.08
47.12%
328.24
281.48
16.61%
300.42
266.73
12.63%
321.68
241.79
33.04%
EBITDA
55.91
56.61
-1.24%
51.87
53.93
-3.82%
46.99
52.54
-10.56%
52.61
35.41
48.57%
EBIDTM
12.18%
17.12%
13.64%
16.08%
13.53%
16.46%
14.06%
12.77%
Other Income
4.99
0.77
548.05%
0.17
0.13
30.77%
0.10
0.08
25.00%
0.92
0.07
1,214.29%
Interest
10.34
8.93
15.79%
10.48
9.06
15.67%
9.73
8.03
21.17%
9.41
8.94
5.26%
Depreciation
10.81
10.23
5.67%
10.72
9.97
7.52%
10.63
10.06
5.67%
10.40
9.81
6.01%
PBT
39.75
38.22
4.00%
30.83
35.03
-11.99%
26.73
34.53
-22.59%
33.72
16.72
101.67%
Tax
12.31
14.23
-13.49%
9.94
11.70
-15.04%
8.68
10.93
-20.59%
10.34
5.34
93.63%
PAT
27.44
23.99
14.38%
20.89
23.33
-10.46%
18.05
23.60
-23.52%
23.37
11.38
105.36%
PATM
5.98%
7.25%
5.50%
6.96%
5.20%
7.39%
6.24%
4.11%
EPS
11.64
10.17
14.45%
8.86
9.78
-9.41%
7.65
9.89
-22.65%
9.91
4.77
107.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Net Sales
1,560.95
1,243.63
1,195.17
1,139.84
1,096.88
501.05
478.50
382.12
312.36
289.49
253.51
Net Sales Growth
23.63%
4.05%
4.85%
3.92%
118.92%
4.71%
25.22%
22.33%
7.90%
14.19%
 
Cost Of Goods Sold
1,059.98
737.72
744.43
735.08
724.24
321.34
301.35
238.85
197.35
184.75
161.04
Gross Profit
500.97
505.91
450.75
404.77
372.65
179.71
177.15
143.27
115.01
104.74
92.46
GP Margin
32.09%
40.68%
37.71%
35.51%
33.97%
35.87%
37.02%
37.49%
36.82%
36.18%
36.47%
Total Expenditure
1,353.57
1,041.76
1,004.68
960.02
924.51
431.87
396.04
315.67
266.61
247.51
214.90
Power & Fuel Cost
-
71.42
59.42
53.93
49.56
29.07
26.48
23.27
19.70
17.82
15.59
% Of Sales
-
5.74%
4.97%
4.73%
4.52%
5.80%
5.53%
6.09%
6.31%
6.16%
6.15%
Employee Cost
-
52.14
47.95
40.19
33.26
19.93
14.77
12.00
10.54
8.69
7.05
% Of Sales
-
4.19%
4.01%
3.53%
3.03%
3.98%
3.09%
3.14%
3.37%
3.00%
2.78%
Manufacturing Exp.
-
127.38
103.21
87.60
75.53
39.18
32.32
25.17
24.22
20.03
16.58
% Of Sales
-
10.24%
8.64%
7.69%
6.89%
7.82%
6.75%
6.59%
7.75%
6.92%
6.54%
General & Admin Exp.
-
14.85
12.81
10.98
10.48
4.86
4.95
3.80
3.14
4.29
4.29
% Of Sales
-
1.19%
1.07%
0.96%
0.96%
0.97%
1.03%
0.99%
1.01%
1.48%
1.69%
Selling & Distn. Exp.
-
34.00
31.16
27.82
28.99
16.21
14.47
11.69
9.99
10.57
9.06
% Of Sales
-
2.73%
2.61%
2.44%
2.64%
3.24%
3.02%
3.06%
3.20%
3.65%
3.57%
Miscellaneous Exp.
-
4.24
5.71
4.42
2.45
1.27
1.71
0.89
1.67
1.37
9.06
% Of Sales
-
0.34%
0.48%
0.39%
0.22%
0.25%
0.36%
0.23%
0.53%
0.47%
0.51%
EBITDA
207.38
201.87
190.49
179.82
172.37
69.18
82.46
66.45
45.75
41.98
38.61
EBITDA Margin
13.29%
16.23%
15.94%
15.78%
15.71%
13.81%
17.23%
17.39%
14.65%
14.50%
15.23%
Other Income
6.18
1.05
4.00
0.00
0.65
0.16
0.63
0.52
1.85
0.81
0.67
Interest
39.96
38.36
40.02
48.02
42.28
17.12
18.66
26.45
14.48
11.86
10.97
Depreciation
42.56
40.06
38.46
36.53
31.02
19.11
17.03
14.48
13.02
11.89
11.08
PBT
131.03
124.50
116.01
95.27
99.72
33.11
47.40
26.04
20.09
19.03
17.23
Tax
41.27
42.20
34.21
26.55
22.47
9.61
18.96
8.47
5.28
4.27
2.72
Tax Rate
31.50%
33.90%
29.49%
27.87%
22.53%
29.02%
40.00%
32.53%
26.28%
22.44%
15.79%
PAT
89.75
82.31
81.80
68.72
77.25
23.50
28.06
16.71
14.08
13.93
13.76
PAT before Minority Interest
89.75
82.31
81.80
68.72
77.25
23.50
28.44
17.57
14.81
14.76
14.50
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.38
-0.86
-0.73
-0.83
-0.74
PAT Margin
5.75%
6.62%
6.84%
6.03%
7.04%
4.69%
5.86%
4.37%
4.51%
4.81%
5.43%
PAT Growth
9.05%
0.62%
19.03%
-11.04%
228.72%
-16.25%
67.92%
18.68%
1.08%
1.24%
 
Unadjusted EPS
38.06
34.41
33.46
28.38
31.90
19.58
23.88
13.64
12.65
12.61
12.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Shareholder's Funds
455.43
400.13
357.40
308.15
163.16
146.45
123.45
111.53
100.12
87.95
Share Capital
23.58
23.86
24.22
24.22
12.11
12.11
11.71
11.71
11.71
11.71
Total Reserves
431.85
376.27
333.18
283.94
151.05
134.34
111.53
99.82
88.41
76.25
Non-Current Liabilities
312.31
296.59
243.78
211.03
290.20
209.85
210.70
233.12
212.60
201.28
Secured Loans
190.53
187.38
176.66
152.72
204.83
138.66
160.86
127.57
123.43
104.95
Unsecured Loans
12.17
14.17
14.57
10.75
62.65
50.16
31.35
89.58
75.75
84.89
Long Term Provisions
16.87
8.39
1.42
0.29
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
620.20
494.31
501.02
482.76
70.10
57.99
59.62
57.40
39.75
65.21
Trade Payables
258.73
196.97
184.90
166.72
65.30
50.18
54.78
54.50
38.89
50.77
Other Current Liabilities
54.94
51.00
43.80
41.53
1.77
1.68
1.33
0.80
0.86
0.73
Short Term Borrowings
305.64
244.66
258.41
252.43
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.89
1.68
13.91
22.08
3.03
6.13
3.51
2.11
0.00
13.71
Total Liabilities
1,387.94
1,191.03
1,102.20
1,001.94
523.46
419.15
403.24
416.63
366.32
367.46
Net Block
602.39
581.09
493.42
448.46
247.84
208.20
205.24
189.94
182.77
183.10
Gross Block
909.20
848.13
725.47
685.21
393.33
332.42
309.85
277.70
255.03
240.68
Accumulated Depreciation
306.81
267.04
232.05
236.75
145.49
124.21
104.61
87.76
72.27
57.58
Non Current Assets
652.55
619.61
536.97
476.40
263.50
213.35
207.43
217.81
197.77
184.75
Capital Work in Progress
28.45
14.28
34.04
16.06
10.37
3.40
0.64
14.67
13.75
1.33
Non Current Investment
10.76
11.94
4.63
4.63
5.28
1.74
1.55
13.20
1.25
0.32
Long Term Loans & Adv.
10.95
12.30
4.88
7.24
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
735.39
571.42
565.23
525.54
259.96
205.81
195.80
198.80
167.41
180.45
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
278.21
209.63
178.35
164.20
91.83
64.41
60.52
66.21
62.36
67.52
Sundry Debtors
373.46
296.81
331.69
314.27
121.34
115.87
113.48
103.29
78.80
74.73
Cash & Bank
4.27
4.17
4.82
3.58
5.27
8.52
3.48
4.02
5.18
7.14
Other Current Assets
79.44
0.00
0.00
0.00
41.52
17.01
18.32
25.27
21.05
31.06
Short Term Loans & Adv.
69.23
60.81
50.37
43.49
40.62
16.01
17.52
24.49
20.22
30.24
Net Current Assets
115.19
77.11
64.20
42.78
189.86
147.82
136.18
141.39
127.66
115.24
Total Assets
1,387.94
1,191.03
1,102.20
1,001.94
523.46
419.16
403.23
416.65
366.33
367.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
69.77
174.75
133.29
104.59
20.56
59.12
64.90
28.39
29.27
PBT
124.50
116.01
95.27
99.72
33.11
47.40
26.04
20.09
19.03
Adjustment
75.12
71.63
79.30
69.40
38.76
38.77
41.71
27.51
24.20
Changes in Working Capital
-105.19
8.47
-21.25
-49.58
-40.22
-13.27
2.39
-15.17
-11.38
Cash after chg. in Working capital
94.44
196.11
153.33
119.53
31.65
72.90
70.14
32.43
31.86
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-24.67
-21.36
-20.03
-14.94
-11.09
-13.80
-5.24
-4.05
-2.59
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.54
-106.98
-98.79
-107.01
-76.36
-30.46
-11.51
-33.16
-25.23
Net Fixed Assets
-72.64
-92.88
-46.34
-322.27
-65.29
-22.98
-19.64
-21.98
Net Investments
1.18
-7.30
-0.01
13.50
-3.23
0.00
12.15
-12.18
Others
-2.08
-6.80
-52.44
201.76
-7.84
-7.48
-4.02
1.00
Cash from Financing Activity
3.92
-68.23
-33.26
1.46
52.55
-23.62
-53.92
3.61
-5.99
Net Cash Inflow / Outflow
0.15
-0.45
1.24
-0.95
-3.25
5.04
-0.53
-1.16
-1.96
Opening Cash & Equivalents
3.15
3.60
3.58
4.53
8.52
3.48
4.02
5.18
7.14
Closing Cash & Equivalent
3.29
3.15
4.82
3.58
5.27
8.52
3.49
4.02
5.18

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Book Value (Rs.)
193.12
167.72
147.58
127.25
67.37
60.47
52.63
47.61
42.26
36.59
ROA
6.38%
7.13%
6.53%
10.13%
4.99%
6.92%
4.29%
3.78%
4.02%
3.95%
ROE
19.24%
21.60%
20.65%
32.78%
15.18%
21.09%
14.97%
14.08%
15.99%
16.92%
ROCE
17.31%
18.50%
18.33%
23.93%
13.12%
20.30%
16.30%
11.03%
10.77%
10.23%
Fixed Asset Turnover
1.44
1.64
1.75
2.19
1.45
1.57
1.42
1.26
1.30
1.16
Receivable days
96.89
89.05
95.59
67.25
82.06
83.04
95.17
98.73
87.26
97.47
Inventory Days
70.52
54.97
50.69
39.52
54.05
45.23
55.64
69.71
73.82
88.06
Payable days
74.00
67.66
65.68
45.51
45.97
46.92
62.87
59.81
63.29
91.38
Cash Conversion Cycle
93.41
76.36
80.60
61.26
90.14
81.35
87.94
108.62
97.79
94.16
Total Debt/Equity
1.20
1.20
1.26
1.45
1.64
1.29
1.56
1.95
2.01
2.22
Interest Cover
4.25
3.90
2.98
3.36
2.93
3.54
1.98
2.39
2.61
2.57

News Update:


  • Aarti Drugs - Quarterly Results
    15th May 2019, 15:00 PM

    Read More
  • Aarti Drugs to buyback 1.20% stake
    15th Mar 2019, 14:17 PM

    The Board of Directors of the Company at its meeting held on March 15, 2019 has approved the same

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.